Stamos Capital Partners’s Eli Lilly LLY Stock Holding History
Bought
Maintained
Sold
Other funds holding LLY
Stamos Capital Partners's LLY Position: Q3 2026 in Review
Stamos Capital Partners reduced its Eli Lilly (LLY) stake by 0.26% in Q3 2026, selling an estimated $16.5K and leaving 5,435 shares worth $6.29M. The position accounts for 0.89% of the portfolio, ranked #40.
Stamos Capital Partners first reported a position in LLY in Q4 2018 and has held it in 17 quarters since. The position peaked at $6.54M in Q2 2026. 4,631 funds tracked by Wall St. Rank hold LLY as of Q3 2026.
- Stamos Capital Partners held 5,435 shares of Eli Lilly worth $6.29M as of Q3 2026.
- Stamos Capital Partners sold 14 Eli Lilly shares in Q3 2026, an estimated $16.5K.
- Eli Lilly made up 0.89% of Stamos Capital Partners's portfolio in Q3 2026, its #40 holding.
- Stamos Capital Partners first reported a position in Eli Lilly in Q4 2018 and has held it in 17 quarters since.
- Stamos Capital Partners's Eli Lilly position peaked at $6.54M in Q2 2026.
- 4,631 funds tracked by Wall St. Rank held Eli Lilly as of Q3 2026.
Based on Stamos Capital Partners's 13F filing for Q3 2026, filed 13 Nov 2026.